Dahong Li Selected Research

Dahong Li Research Topics

Disease

22	Neoplasms (Cancer) 12/2022 - 06/2012
7	Breast Neoplasms (Breast Cancer) 12/2022 - 10/2018
4	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 01/2013
3	Neoplasm Metastasis (Metastasis) 12/2022 - 01/2020
3	Triple Negative Breast Neoplasms 12/2021 - 01/2020
2	Hypoxia (Hypoxemia) 09/2021 - 05/2017
2	Prostatic Neoplasms (Prostate Cancer) 06/2021 - 02/2018
2	Leukemia 01/2020 - 02/2018
2	Liver Neoplasms (Liver Cancer) 02/2018 - 07/2017
1	Lung Neoplasms (Lung Cancer) 06/2022
1	Melanoma (Melanoma, Malignant) 06/2022
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 06/2021
1	Leukemia L1210 06/2021
1	Pancreatic Neoplasms (Pancreatic Cancer) 05/2021
1	Wounds and Injuries (Trauma) 02/2020
1	Colonic Neoplasms (Colon Cancer) 01/2020
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020
1	Pathologic Processes 01/2020
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 06/2019
1	Obesity 12/2018
1	Diabetes Mellitus 08/2018
1	Cardiomyopathies (Cardiomyopathy) 08/2018
1	Osteoporosis 08/2018
1	Diabetes Complications 08/2018
1	Insulin Resistance 08/2018
1	Stomach Neoplasms (Stomach Cancer) 06/2012

Drug/Important Bio-Agent (IBA)

11	oridoninIBA 01/2020 - 06/2012
5	Pharmaceutical PreparationsIBA 01/2020 - 01/2017
3	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 05/2021 - 01/2020
3	Biological ProductsIBA 01/2019 - 06/2012
2	Mechlorethamine (Nitrogen Mustard)FDA Link 12/2022 - 01/2021
2	DNA (Deoxyribonucleic Acid)IBA 12/2022 - 08/2016
2	1,2,5-oxadiazole 2-oxideIBA 01/2021 - 06/2012
2	Carbolines (Beta-Carbolines)IBA 01/2021 - 01/2021
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 02/2020 - 06/2012
2	DiterpenesIBA 02/2018 - 01/2013
1	ChromonesIBA 12/2022
1	sinomenineIBA 12/2022
1	Phosphotransferases (Kinase)IBA 06/2022
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 06/2022
1	p21-Activated KinasesIBA 06/2022
1	evodiamineIBA 12/2021
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 12/2021
1	NitroreductasesIBA 09/2021
1	Immunoconjugates (Immunoconjugate)IBA 06/2021
1	SilverIBA 05/2021
1	Therapeutic UsesIBA 05/2021
1	Sincalide FDA Link 01/2021
1	GasotransmittersIBA 02/2020
1	Carbon MonoxideIBA 02/2020
1	chelidonineIBA 01/2020
1	IntegrinsIBA 01/2020
1	HAO472IBA 01/2020
1	EstersIBA 06/2019
1	Non-Receptor Type 1 Protein Tyrosine PhosphataseIBA 12/2018
1	LipidsIBA 08/2018
1	Silybin (Lagosa)IBA 08/2018
1	Cytochromes c (Cytochrome c)IBA 02/2018
1	Caspase 3 (Caspase-3)IBA 02/2018
1	enmeinIBA 02/2018
1	DAPIIBA 11/2017
1	5,5',6,6'- tetrachloro- 1,1',3,3'- tetraethylbenzimidazolocarbocyanineIBA 11/2017
1	Annexin A5IBA 11/2017
1	Antineoplastic Agents (Antineoplastics)IBA 07/2017
1	scutellarinIBA 07/2017
1	NAD (NADH)IBA 05/2017
1	ProdrugsIBA 05/2017
1	EnzymesIBA 05/2017
1	Oxidoreductases (Dehydrogenase)IBA 05/2017
1	quinone (benzoquinone)IBA 05/2017
1	Kaurane DiterpenesIBA 01/2017
1	LactonesIBA 01/2017
1	RNA (Ribonucleic Acid)IBA 08/2016
1	Antimutagenic Agents (Antimutagens)IBA 08/2016
1	Proteins (Proteins, Gene)FDA Link 08/2016
1	NitrogenIBA 07/2014
1	compound 17IBA 06/2013
1	CaspasesIBA 06/2013
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2013
1	Spironolactone (Aldactone)FDA LinkGeneric 01/2013
1	kaureneIBA 01/2013

Therapy/Procedure

6	Therapeutics 05/2021 - 01/2017
1	Topical Administration 02/2020